Enabling precision medicine cohort studies at the community level
By Harsha Rajasimha, Ph.D., Founder and CEO The precision medicine paradigm is all about targeting medicines to patient cohorts that are most likely to benefit from them. Since the one-size-fits-all model has been shown not to work, […]